TCIM
GOSS icon

TIAA CREF Investment Management’s Gossamer Bio GOSS Stock Holding History

TIAA CREF Investment Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$663K Buy
+30,577
New +$638K ﹤0.01% 2496

Other funds holding GOSS

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TIAA CREF Investment Management's GOSS Position: Q1 2019 in Review

TIAA CREF Investment Management opened a new position in Gossamer Bio (GOSS) in Q1 2019: 30,577 shares worth $663K. The stake represents ﹤0.01% of the portfolio and ranks #2496 among its holdings.

71 funds tracked by Wall St. Rank hold GOSS as of Q1 2019.

  • TIAA CREF Investment Management held 30,577 shares of Gossamer Bio worth $663K as of Q1 2019.
  • Gossamer Bio was a new TIAA CREF Investment Management position in Q1 2019.
  • Gossamer Bio made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2496 holding.
  • 71 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.